T36.5X2A Poisoning by aminoglycosides, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by aminoglycosides, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm resulting in poisoning by aminoglycosides during an initial encounter. It applies when aminoglycoside exposure leads to harmful effects due to deliberate overdose or self-administration. Documentation should specify the aminoglycoside involved, the intentional nature of the event, and that this is the initial encounter for management.

Causes

Intentional poisoning may result from deliberate overdose, self-administration, or self-inflicted exposure to aminoglycosides. This can occur in clinical or non-clinical settings, often related to suicidal ideation or self-harm behaviors. Adverse effects may stem from cumulative toxicity or idiosyncratic reactions, even at therapeutic doses.

Risk Factors

• Prior history of aminoglycoside toxicity or renal impairment.
• Psychiatric conditions or suicidal ideation.
• Access to aminoglycosides (e.g., prescription or stored medications).
• Substance use disorders increasing self-harm risk.
• Lack of supervision or support in high-risk populations.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain.
• Renal: Decreased urine output, elevated creatinine.
• Ototoxicity: Tinnitus, hearing loss, vertigo.
• Neurological: Dizziness, confusion, muscle weakness.
• Allergic: Rash, pruritus, or anaphylaxis (rare).

Diagnosis

Evaluation includes clinical assessment of symptoms, medication history, and toxicology screening. Laboratory tests may assess renal function, electrolytes, and aminoglycoside levels. Imaging or other studies may be used to rule out complications. Documentation must confirm intentional self-harm and initial encounter status.

Treatment Options

Management focuses on stabilizing the patient, decontamination (if appropriate), and supportive care. Specific treatments may include antidotes (if available), renal replacement therapy for toxicity, and monitoring for organ dysfunction. Psychiatric evaluation and intervention are critical for self-harm cases.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of intervention, and underlying health. Early treatment improves outcomes, but severe toxicity may lead to permanent organ damage. Follow-up includes monitoring renal and auditory function, psychiatric care, and medication safety education.

Complications

• Acute kidney injury or renal failure.
• Permanent hearing loss or vestibular damage.
• Neurological deficits (e.g., muscle weakness, confusion).
• Electrolyte imbalances.
• Psychiatric sequelae from self-harm.

Lifestyle & Prevention

• Secure storage of medications to prevent access.
• Patient education on medication safety and self-harm risks.
• Regular psychiatric evaluations for at-risk individuals.
• Monitoring of high-risk patients during therapy.
• Collaboration with mental health providers for prevention.

When to Seek Professional Help

Seek immediate care for suspected intentional poisoning, especially with symptoms like severe nausea, reduced urine output, or neurological changes. Emergency services should be contacted for self-harm or overdose situations.

Tips for Medical Coders

Document the specific aminoglycoside involved, confirm intentional self-harm, and note the initial encounter. Ensure clinical details support the diagnosis and intent, as coding requires clear documentation of the event’s nature and timing.